JUNS (Jupiter Neurosciences) Interest Expense: $-0.18 Mil (TTM As of Mar. 2026)

What is Jupiter Neurosciences Interest Expense?

Jupiter Neurosciences JUNS +3.00% 4 Interest Expense is $-0.18 Mil as of Mar. 2026. GuruFocus rates JUNS with a GF Score™ of 4/100. The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jupiter Neurosciences's interest expense for the three months ended in Mar. 2026 was $ -0.12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jupiter Neurosciences's Operating Income for the three months ended in Mar. 2026 was $ -1.96 Mil. Jupiter Neurosciences's Interest Expense for the three months ended in Mar. 2026 was $ -0.12 Mil. Jupiter Neurosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jupiter Neurosciences (NAS:JUNS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jupiter Neurosciences's Interest Expense for the three months ended in Mar. 2026 was $-0.12 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-1.96 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $0.00 Mil.

Jupiter Neurosciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Jupiter Neurosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Jupiter Neurosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Jupiter Neurosciences's Interest Expense can be seen below:

Jupiter Neurosciences Interest Expense Chart

Jupiter Neurosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.11

-0.74

-0.22

-0.25

-0.07

Jupiter Neurosciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.00	-0.00	-0.00	-0.06	-0.12

4GF Score

Jupiter Neurosciences Inc JUNS

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Jupiter Neurosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.18 Mil mean?

Jupiter Neurosciences (JUNS) has a Interest Expense of $-0.18 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Jupiter Neurosciences and its competitors.

Is Jupiter Neurosciences' Interest Expense too high?

Jupiter Neurosciences' current Interest Expense is $-0.18 Mil. Overall, Jupiter Neurosciences has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.

How does Jupiter Neurosciences' Interest Expense compare to ZEOX and LEXX?

Jupiter Neurosciences' Interest Expense of $-0.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Jupiter Neurosciences and its competitors. Jupiter Neurosciences's current Interest Expense is $-0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Jupiter Neurosciences stock overvalued right now?

Jupiter Neurosciences (JUNS) has a current Interest Expense of $-0.18 Mil. The current Interest Expense is $-0.18 Mil. Jupiter Neurosciences' overall GF Score™ is 4/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Jupiter Neurosciences (JUNS), the current Interest Expense is $-0.18 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jupiter Neurosciences Business Description

Industry Healthcare Biotechnology

Comparable Companies ZEOX LEXX GDTC INAB TRAW HOOK ICU COCP CALC LNAI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1001 North US Highway 1, Suite 504, Jupiter, FL, USA, 33477

Website https://www.jupiterneurosciences.com

Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.

4GF Score

Get the complete analysis for JUNS

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20

Price

View JUNS Analysis

See Interest Expense data for all stocks →